Investigation of responsiveness to thyrotropin-releasing hormone in growth hormone-producing pituitary adenomas
- PMID: 24348552
- PMCID: PMC3857837
- DOI: 10.1155/2013/159858
Investigation of responsiveness to thyrotropin-releasing hormone in growth hormone-producing pituitary adenomas
Abstract
Objective. The aim of this study was to investigate how the paradoxical response of GH secretion to TRH changes according to tumor volumes. Methods. Patients with newly diagnosed acromegaly were classified as either TRH responders or nonresponders according to the results of a TRH stimulation test (TST), and their clinical characteristics were compared according to responsiveness to TRH and tumor volumes. Results. A total of 41 acromegalic patients who underwent the TST were included in this study. Between TRH responders and nonresponders, basal GH, IGF-I levels, peak GH levels, and tumor volume were not significantly different, but the between-group difference of GH levels remained near significant over the entire TST time. ΔGHmax-min during the TST were significantly different according to the responsiveness to TRH. Peak GH levels and ΔGHmax-min during the TST showed significantly positive correlations with tumor volume with higher levels in macroadenomas than in microadenomas. GH levels over the entire TST time also remained significantly higher in macroadenomas than in microadenomas. Conclusion. Our data demonstrated that the paradoxical response of GH secretion to TRH in GH-producing pituitary adenomas was not inversely correlated with tumor volumes.
Figures



Similar articles
-
[Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].Minerva Chir. 1993 Nov;48(21-22):1337-40. Minerva Chir. 1993. PMID: 8152567 Italian.
-
Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.Neuropeptides. 1993 Dec;25(6):363-75. doi: 10.1016/0143-4179(93)90056-g. Neuropeptides. 1993. PMID: 8127416
-
Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone.J Clin Endocrinol Metab. 2012 Aug;97(8):2741-7. doi: 10.1210/jc.2012-1125. Epub 2012 May 8. J Clin Endocrinol Metab. 2012. PMID: 22569237
-
The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.Clin Endocrinol (Oxf). 2001 Mar;54(3):309-16. doi: 10.1046/j.1365-2265.2001.01237.x. Clin Endocrinol (Oxf). 2001. PMID: 11298082
-
Investigation of hypothalamic-pituitary disease.Clin Endocrinol Metab. 1983 Nov;12(3):509-34. doi: 10.1016/s0300-595x(83)80054-1. Clin Endocrinol Metab. 1983. PMID: 6323063 Review.
Cited by
-
Growth hormone and risk for cardiac tumors in Carney complex.Endocr Relat Cancer. 2016 Sep;23(9):739-46. doi: 10.1530/ERC-16-0246. Epub 2016 Jul 18. Endocr Relat Cancer. 2016. PMID: 27535175 Free PMC article.
-
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e70-84. doi: 10.1210/clinem/dgz093. J Clin Endocrinol Metab. 2020. PMID: 31650157 Free PMC article.
-
A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.Front Endocrinol (Lausanne). 2021 Feb 23;11:614981. doi: 10.3389/fendo.2020.614981. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33708174 Free PMC article. Review.
References
-
- Hanew K, Kokubun M, Sasaki A. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly. Journal of Clinical Endocrinology and Metabolism. 1980;51(2):292–297. - PubMed
-
- Irie M, Tsushima T. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. Journal of Clinical Endocrinology and Metabolism. 1972;35(1):97–100. - PubMed
-
- Schalch DS, Gonzalez-Barcena D, Kastin AJ, Schally AV, Lee LA. Abnormalities in the release of TSH in response to thyrotropin-releasing hormone (TRH) in patients with disorders of the pituitary, hypothalamus and basal ganglia. Journal of Clinical Endocrinology and Metabolism. 1972;35(4):609–615. - PubMed
-
- Biermasz NR, Smit JWA, van Dulken H, Roelfsema F. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Clinical Endocrinology. 2002;56(3):313–319. - PubMed
-
- Czernichow P, Dauzet MC, Broyer M, Rappaport R. Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. Journal of Clinical Endocrinology and Metabolism. 1976;43(3):630–637. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources